Edesa Biotech, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
13.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.39
|
-0.02
|
0.37
|
94.87%
|
|
2022-06-30
|
-0.43
|
-0.37
|
0.06
|
13.95%
|
|
2022-03-31
|
-0.37
|
-0.33
|
0.04
|
10.81%
|
|
2021-12-31
|
-0.40
|
-0.33
|
0.07
|
17.50%
|
|
2021-09-30
|
-0.37
|
-0.27
|
0.10
|
27.03%
|
|
2021-06-30
|
-0.32
|
-0.36
|
-0.04
|
-12.50%
|
|
2021-03-31
|
-0.29
|
-0.19
|
0.10
|
34.48%
|
|
2020-12-31
|
-0.19
|
-0.26
|
-0.07
|
-36.84%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.00
|
|
2022-09-30
|
-1.05
|
|
2021-09-30
|
-1.08
|
|
2020-09-30
|
-0.74
|
|
2019-09-30
|
-4.27
|
|
2018-09-30
|
-4.77
|
|
2017-09-30
|
-3.47
|
|
2016-09-30
|
-10.77
|
|
2015-09-30
|
-7.25
|
|
2014-09-30
|
-137.14
|
|
2012-09-30
|
-49.24
|
|
2011-09-30
|
-73.30
|
|
2010-09-30
|
-16.09
|